(Q54514641)

30 May 2018

title

Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. (English)

1 reference

30 May 2018

author

Larry Norton

7

1 reference

30 May 2018

author name string

Yong Hannah Wen

1

1 reference

30 May 2018

Alice Ho

2

1 reference

30 May 2018

Sujata Patil

3

1 reference

30 May 2018

Muzaffar Akram

4

1 reference

30 May 2018

Jeff Catalano

5

1 reference

30 May 2018

Anne Eaton

6

1 reference

30 May 2018

Robert Benezra

8

1 reference

30 May 2018

Edi Brogi

9

1 reference

30 May 2018

language of work or name

English

0 references

publication date

27 April 2012

1 reference

30 May 2018

Breast Cancer Research and Treatment

published in

1 reference

30 May 2018

volume

135

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

93-102

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s10549-012-2070-0

exact match

0 references

cites work

Triple negative breast cancers: clinical and prognostic implications.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

A role for Id proteins in mammary gland physiology and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The spectrum of apocrine lesions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Role of Id proteins in embryonic and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Increased expression of Id family proteins in small cell lung cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Increased inhibitor of differentiation 4 (id4) expression in glioblastoma: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Frequent DNA methylation but not mutation of the ID4 gene in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

BRCA1 transcriptionally regulates genes involved in breast tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2070-0

10.1007/S10549-012-2070-0

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018